{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:29:42Z","timestamp":1791160182480,"version":"4.1.0"},"reference-count":26,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2007,6,12]],"date-time":"2007-06-12T00:00:00Z","timestamp":1181606400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["obgyn.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BJOG"],"published-print":{"date-parts":[[2007,7]]},"abstract":"<jats:p><jats:bold>Background\u2002<\/jats:bold> Studies examining the use of C\u2010reactive protein (CRP) as a predictor of chorioamnionitis in preterm prelabour rupture of membranes (PPROM) report highly conflicting results. Despite this, CRP is commonly used for the early diagnosis of chorioamnionitis.<\/jats:p><jats:p><jats:bold>Objective\u2002<\/jats:bold> To determine the diagnostic accuracy of CRP in the detection of chorioamnionitis in women with PPROM.<\/jats:p><jats:p><jats:bold>Design\u2002<\/jats:bold> Systematic review.<\/jats:p><jats:p><jats:bold>Search strategy\u2002<\/jats:bold> Studies were identified from MEDLINE (1966\u20132006), EMBASE (1974\u20132006), PubMed and the Cochrane Library (2005) and from reference lists from primary studies and reviews.<\/jats:p><jats:p><jats:bold>Selection criteria\u2002<\/jats:bold> Only studies of good methodological quality that evaluated the diagnostic performance of CRP in chorioamnionitis in women with PPROM were selected.<\/jats:p><jats:p><jats:bold>Data collection and analysis\u2002<\/jats:bold> Positive and negative likelihood ratios (LR) and diagnostic odds ratios (DOR) were calculated. An attempt was made at pooling data for meta\u2010analysis, but this was considered inappropriate due to the significant unexplained heterogeneity between studies.<\/jats:p><jats:p><jats:bold>Main results\u2002<\/jats:bold> There were eight primary studies comprising 610 cases which met the inclusion criteria. There was wide variation in the positive and negative LR and DOR between the studies, with significant lack of precision demonstrated by wide confidence intervals. Three of the studies concluded that CRP was a useful diagnostic tool for chorioamnionitis (DOR ranging from 4.2 to 191.6), although one of them suggested a higher CRP threshold. The other five studies concluded the opposite (DOR ranging from 1.4 to 17.7).<\/jats:p><jats:p><jats:bold>Author\u2019s conclusions\u2002<\/jats:bold> There is no clear evidence to support the use of CRP for the early diagnosis of chorioamnionitis. Further research is required to address the contradictory findings of diagnostic accuracy.<\/jats:p>","DOI":"10.1111\/j.1471-0528.2007.01385.x","type":"journal-article","created":{"date-parts":[[2007,6,12]],"date-time":"2007-06-12T16:10:54Z","timestamp":1181664654000},"page":"796-801","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":105,"title":["Use of C\u2010reactive protein as a predictor of chorioamnionitis in preterm prelabour rupture of membranes: a systematic review"],"prefix":"10.1111","volume":"114","author":[{"given":"RD","family":"Trochez\u2010Martinez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RF","family":"Lamont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,6,12]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1080\/10647440500068321"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198810133191503"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0028-2243(90)90139-R"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(90)91016-6"},{"key":"e_1_2_7_6_2","unstructured":"Cochrane Methods Working Group on Systematic Reviews of Screening and Diagnostic Tests.Screening and Diagnostic Tests: Recommended Methods 1996.http:\/\/www.nihs.go.jp\/dig\/cochrane\/cochrane\/sadtdoc1.htm. Accessed 14 December 2005."},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.323.7305.157"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-2115(00)00463-2"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-120-8-199404150-00008"},{"key":"e_1_2_7_10_2","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1001\/jama.1994.03510290071040","article-title":"Users\u2019 guides to the medical literature. III: How to use an article about a diagnostic test. A. Are the results of the study valid? Evidence\u2010Based Medicine Working Group","volume":"271","author":"Jaeschke R","year":"1994","journal-title":"JAMA"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1994.03510330081039"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.1.89"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.282.11.1061"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-6-31"},{"key":"e_1_2_7_15_2","first-page":"1037","article-title":"Usefulness of determination of granulocyte elastase plasma level, C\u2010reactive protein and white blood cell count in prediction of intrauterine infection in pregnant women after PPROM","volume":"74","author":"Bankowska E","year":"2003","journal-title":"Ginekol Pol"},{"key":"e_1_2_7_16_2","first-page":"49","article-title":"C\u2010reactive protein with premature rupture of membranes and premature labor","volume":"62","author":"Farb H","year":"1983","journal-title":"Obstet Gynecol"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.1987.tb02316.x"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(83)91104-3"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02390652"},{"key":"e_1_2_7_20_2","first-page":"615","article-title":"Intrauterine infection. I. The role of C\u2010reactive protein, white blood cell count and erythrocyte sedimentation rate in the prediction of chorioamnionitis in cases of premature rupture of membranes","volume":"69","author":"Nowak M","year":"1998","journal-title":"Ginekol Pol"},{"issue":"1","key":"e_1_2_7_21_2","first-page":"S360","article-title":"The role of maternal serum C\u2010reactive protein and white blood cell count in the prediction of chorioamnionitis in women with premature rupture of membranes","volume":"84","author":"Sereepapong W","year":"2001","journal-title":"J Med Assoc Thai"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0029-7844(96)00339-0"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1159\/000264246"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1520-6661(199609\/10)5:5<227::AID-MFM1>3.0.CO;2-J"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1590\/S0066-782X2003001000002"},{"key":"e_1_2_7_26_2","unstructured":"US Department of Health and Human Services Food and Drug Administration Centre for Devices and Radiological Health Office of In Vitro Diagnostic Device Evaluation and Safety Division of Chemistry and Toxicology Devices. Review criteria for assessment of C\u2010Reactive Protein (CRP) High Sensitivity C\u2010Reactive Protein (hsCRP) and Cardiac C\u2010Reactive Protein (cCRP) assays.2005[www.fda.gov\/cdrh\/oivd\/guidance\/1246.pdf]. Accessed 28 February 2007."},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-2115(03)00084-8"}],"container-title":["BJOG: An International Journal of Obstetrics &amp; Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1471-0528.2007.01385.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1471-0528.2007.01385.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T04:23:34Z","timestamp":1697430214000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1111\/j.1471-0528.2007.01385.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6,12]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["10.1111\/j.1471-0528.2007.01385.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1471-0528.2007.01385.x","archive":["Portico"],"relation":{},"ISSN":["1470-0328","1471-0528"],"issn-type":[{"value":"1470-0328","type":"print"},{"value":"1471-0528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,6,12]]},"assertion":[{"value":"2007-06-12","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}